581083-28-5Relevant academic research and scientific papers
HEPATITIS C INHIBITOR COMPOUNDS
-
Page/Page column 46, (2013/03/26)
Compounds of Formula (I) wherein n, X1, X2, R1, R2, Y1, Y2 and RA are defined herein, are useful for the treatment of hepatitis C viral infection.
HEPATITIS C INHIBITOR COMPOUNDS
-
Page/Page column 69-70, (2013/03/26)
A compound of formula (I) useful for the treatment or prevention of hepatitis C viral infection, (Formula (I)) wherein: X1 and X2 are each independently CRB or N; RB is H, (C1-6)alkyl, (C1-6/sub
Efficient synthesis of bromocyclopenta[b]indoles via a bromination - Reduction sequence
Lachance, Nicolas,Chan, Wing Yan
, p. 289 - 295 (2007/10/03)
Substituted cyclopenta[b]indoles are selectively brominated in good yields with excess pyridine - Br2 charge-transfer complex (PyBr2) in a one-pot reaction to provide 5 and/or 7-bromoindoles. The mechanism involves the formation of a
